🔎 Trials Near Me

Akèy › Limfòm Burkitt › New York › Queens

Etid klinik pou Limfòm Burkitt nan Queens, NY

6 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi lwen
  • NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
366 Days – 46 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Ap rekriteFaz 3
  • Long Island Jewish Medical Center, New Hyde Park · 9 mi lwen
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
Laj 18 a 39 · Tout sèks · Mizajou Oct 2, 2026 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Ap rekriteFaz 2
  • Long Island Jewish Medical Center, New Hyde Park · 9 mi lwen
  • Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Ap rekriteFaz 2
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi lwen
365 Days · Tout sèks · Mizajou Sep 25, 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi lwen
  • NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
Laj 1 a 30 · Tout sèks · Mizajou Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi lwen
  • NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

Etid Limfòm Burkitt nan lòt vil

Lòt etid nan Queens

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.